PODD
HOLD / NEUTRALMeanRevComposite
45.60
Technical
16.70
Fundamental
55.20
Rank
—
Price
145.42
Hurst
0.27
As of
Aug 25, 2026
Daily
Insulet Corporation
HealthcareMedical DevicesInsulet Corporation manufactures and distributes insulin delivery systems for diabetes patients globally, with its primary Omnipod platform offering multiple versions including an automated system that syncs with continuous glucose monitors via Bluetooth, and a smartphone-controlled pod model. The company also produces drug delivery pods for Amgen's chemotherapy support product and sells through pharmacies and independent distributors.
Market cap
$10.4B
P/E (trailing)
28.03
P/E (forward)
19.38
PEG ratio
1.18
Dividend yield
0.00%
Beta
1.10
52w range
126.40 – 354.88
Return on equity
+26.02%
Profit margin
+12.29%
Revenue growth
+23.50%
Earnings growth
+328.60%
Price history
1Y: 149.68 (-52.2%) · range 130.47–346.36
Cycle position
49/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 34 · NOT READY · exit proximity 0
Conviction
31/ 100 · maturity 71%
VScore.3219
Buildup.2328
EMA entry setup.2834
Fundamentals.1755
Volume profile
POC
141.75
Price vs POC
+5.6%
Overhead supply
34%
Runway
open sky
Value area 131.05–153.38 · 34% of 120d volume overhead · moderate overhead
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -11.71% | +1.65% | mature |
| 40d | +0.59% | +1.65% | 36/40d |